The Use of Cell Therapies for Autoimmune Diseases: MSCs from Biology to Clinical Application

.This 1.5-day training course is designed to teach you the applications of MSCs for treating auto-immune diseases, including rheumatic diseases (systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis), immune-neurological diseases (multiple-sclerosis, autism) and gastrointestinal diseases (Crohn's disease) as well as European ATMP framework.

You will also gain an understanding of the regulatory requirements for using MSCs in clinical applications, specifically on the study design, conduct, analysis and recommendations for developing clinical trials.

Course Content:
  • MSC biology, regulatory requirements, and statistical approaches for clinical applications.
  • ATMP framework in Europe.
  • Applications and mechanisms of MSCs for CGT auto-immune diseases.
  • Manuscript - Recommendations for clinical trials.
Learning Outcome:
  • Have a basic understanding of MSC biology.
  • Know the statistical considerations for clinical trial design when using MSC to treat auto-immune diseases.
  • Understand the process behind the production, regulation, and quality of MSC cell products.
  • Have an understanding of the clinical applications of MSCs for auto-immune diseases.
  • Understand the key principles for developing clinical trials.
Price (USD):
ISCT Member

Non Member

(registration fee includes e-membership for 2024)

Students/Residents/Postdocs/Fellows $195 $240
Others $295 $470

Cancellation Policy:
 Registration cancellation must be made by email to at least twenty (20) business days before the course start date. A 10% administrative fee is applied to all cancellations.  Registration fee is non-refundable if it is cancelled within twenty (20) business days of the course start date.

    Upcoming Course Dates:
    • January 25–January 26, 2024
      Deadline to register:  November 30, 2023

      Course will be conducted in English, in-person at Hôpital Saint-Louis AP-HP, Paris, France.

      Designed for:
      • Clinicians and clinicians-in-training, researchers, and pharmacists looking to increase knowledge on the use of MSCs from lab to clinical application for CGT in auto-immune diseases.
      • 1.5-days, in-person interactive training course
      • Hôpital Saint-Louis AP-HP, Paris, France 

      Eligibility requirements:

      • None
      Contact us:

        If you need help with registration or have questions, please contact us.

        upon completion, you will receive:
        • Certificates of course completion from ISCT.
        • EBAH-CME certificate upon completion of the course.

        This course consists of 12 CME credits, and it has been accepted by the European Board for Accreditation in Hematology (EBAH).

        Planning Committee:

        Headshot of Dominique Farge

        Dominique Farge, MD, PhD 
        Regional Vice-President Elect
        St Louis Hospital Assistance Publique-Hôpitaux De Paris
        Paris-Cité University, Paris, France

        Fermín Sánchez‐Guijo, MD, PhD
        Regional Vice-President
        IBSAL-Hospital Universitario De Salamanca
        Salamanca, Spain

        Massimiliano Gnecchi, MD, PhD, FESC
        University of Pavia & IRCCS Policlinico
        San Matteo Hospital, Pavia, Italy



        Host institution:
        Site of the Saint-Louis Hospital, located in the 10th arrondissement of Paris